Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000434437

Medchemexpress LLC NBD-557 | 333352-59-3 | 99.4% | C17H24BrN3O2 | 1 ML
SDP

Catalog No. 5000434437
Encompass_Preferred

NBD-557 is a potential HIV-1 inhibitor and a small molecule organic compound with drug-like properties. It exhibits potent cell fusion and virus-cell fusion inhibitory activity at low micromolar levels.

  • Targets viral entry by inhibiting the binding of HIV-1 envelope glycoprotein gp120 to the cellular receptor CD4.
  • Active against both X4 and R5 viruses, suggesting its anti-HIV-1 activity is not dependent on coreceptor tropism.
  • Binds to unliganded HIV-1 gp120 but not to the cellular receptor CD4.
  • Active against HIV-1 laboratory-adapted strains, including an AZT-resistant strain, and HIV-1 primary isolates.

Catalog No. 50-004-34437 Supplier Medchemexpress LLC Supplier No. HY7664910MM/1ML
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

NBD-557 is a potential HIV-1 inhibitor and a small molecule organic compound with drug-like properties. It exhibits potent cell fusion and virus-cell fusion inhibitory activity at low micromolar levels.

  • Targets viral entry by inhibiting the binding of HIV-1 envelope glycoprotein gp120 to the cellular receptor CD4.
  • Active against both X4 and R5 viruses, suggesting its anti-HIV-1 activity is not dependent on coreceptor tropism.
  • Binds to unliganded HIV-1 gp120 but not to the cellular receptor CD4.
  • Active against HIV-1 laboratory-adapted strains, including an AZT-resistant strain, and HIV-1 primary isolates.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.